发明名称 QUINAZOLINE BASED EGFR INHIBITORS CONTAINING A ZINC BINDING MOIETY
摘要 The present invention relates to quinazoline containing zinc-binding moiety based derivatives of formula I that have enhanced and unexpected properties as inhibitors of epidermal growth factor receptor tyrosine kinase (EGFR-TK) and their use in the treatment of EGFR-TK related diseases and disorders such as cancer.
申请公布号 KR20130028970(A) 申请公布日期 2013.03.20
申请号 KR20137002341 申请日期 2007.09.10
申请人 CURIS, INC. 发明人 QIAN CHANGGENG;CAI XIONG;GOULD STEPHEN;ZHAI HAIXIAO
分类号 C07D239/86;A61K31/517;A61P35/00;C07D239/94 主分类号 C07D239/86
代理机构 代理人
主权项
地址